The 13 April OHE Lunchtime Seminar with Prof William Comanor was attended by about 40 people, hailing from academia, the pharmaceutical and biotechnology industries, consultancies, physicians’ associations, and government.
The OHE has won a £325,000 grant from the UK Department of Health that focuses on developing a new health status index – the 5 level EQ-5D --that will capture smaller changes in health related quality of life.
In a recent OHE Briefing, five leading European experts in health economics provide a comprehensive international review of changes in health economic evaluation and the reasons for them. The authors express concern that the basis for health care decision making today has evolved away from the societal perspective of cost benefit analysis to the payer perspective of cost-effectiveness analysis.
Prof William S. Comanor, University of California, is renowned for his expertise on the economics of the pharmaceutical industry. On Tuesday, 13 April, he will be joining us at OHE for a lunchtime seminar.